--2025/Q1-- / 7.510B--
--2024/Q4-- / 7.681B--
Oct 30, 20242024/Q38.012B / 8.007B--
Jul 31, 20242024/Q27.884B / 7.493B--
May 1, 20242024/Q17.363B / 7.060B--
US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
- 34.080
- -0.040-0.12%
Close Dec 27 16:00 ET
- 34.080
- 0.0000.00%
Post 19:37 ET
69.53BMarket Cap22.41P/E (TTM)
34.170High33.870Low3.17MVolume33.970Open34.120Pre Close108.06MTurnover0.16%Turnover Ratio11.34P/E (Static)2.04BShares44.84752wk High3.96P/B67.32BFloat Cap32.82552wk Low1.60Dividend TTM1.98BShs Float44.847Historical High4.69%Div YieldTTM0.88%Amplitude6.373Historical Low34.042Avg Price1Lot Size
GlaxoSmithKline Key Stats
GlaxoSmithKline Q3 2024 Earnings Date
Currency：USDOct 30, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 10.71B | 10.72B | +6.88M |
| Beat Est. | +7.72% | +7.79% | +0.06% |
| EPS | 0.16 | -0.04 | -0.19 |
| Miss Est. | -83.36% | -104.31% | -124.08% |
Analyst Rating
Dec 18, 2024
GlaxoSmithKline Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: GBP
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
GlaxoSmithKline Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Price
% Chg
No Data
